Altimmune ALT
NASDAQ ALT
$2.23 -0.07 (-3.04%)
At close: Oct 21, 2026 · 4:00 PM EDT

Altimmune (ALT) Preferred Shares (2016)

Updated

Altimmune (ALT) posted Preferred Shares of $5,993 for Q4 2016.

Analysis

Altimmune (ALT) Preferred Shares (2016) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Altimmune 411.69 Mn -730.54 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2016 5,993.00
API Access

Altimmune Preferred Shares API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-shares&ticker=ALT&period=max&api_key=YOUR_API_KEY